Psychometric properties of the Death Anxiety Scale in patients with ischemic cardiomyopathy
e201910079
Keywords:
Ischemic heart disease, Death, Attitude to death, Anxiety, PsychometricsAbstract
Background: Ischemic cardiomyopathy is a major public health concern in Spain. Death from ischemic disease accounts for approximately a third of all deaths due to cardiovascular disease, and imposes a serious burden on already overstretched public health system owing to the tendency to chronicity. This study aimed to evaluate the psychometric properties of Templer’s Death Anxiety Scale (DAS) in a sample of patients with ischemic cardiomyopathy (acute myocardial infarction and angina pectoris).
Methods: This study applied the Spanish version of Templer’s Death Anxiety Scale (DAS). The sample consisted of 141 patients (61% men) with ischemic cardiomyopathy, mean agede 71.57 years (SD=5.76). A descriptive statistical analysis was performed, and factorial analysis of the principal components.
Results: The corrected element-total correlation was positive in all items, with values ranging from 0.32 and 0.54. Four factors jointly explained 51.85% of the data variance. The reliability coefficients were high in all of the variables analysed, with a total Cronbach Alpha of 0.77.
Conclusions: The results obtained in this study revealed ischemic cardiomyopathy was susceptible to the process of death anxiety. This underscores the need for educating patients with this pathology to help them adapt to the process of chronicity, and to develop an understanding of the naturalization process of dying bearing in mind each person’s multidimensionality.
Downloads
References
Tomás-Sabado J, Fernández-Narváez P, Fernández-Donaire L et al. Revision of the diagnostic label ‘’death anxiety’’. Enferm Clin. 2007;17:152-156.
Heather T, Kamitsuru S (eds). NANDA Nursing Diagnoses: Definitions and Classification 2018-2020. 11th ed. New York: Thieme Medical Publishers, 2017.
Tomás-Sabado J. Miedo y ansiedad ante la muerte. Madrid: Herder Editorial, 2016.
Rivera-Ledesma A, Montero-López M, Sandoval-Ávila R. Templer´s Death Anxiety Scale: Psychometric Properties in Terminal Chronic Renal Failure. Journal of Behavior, Health & Social Issues. 2010;2:83-91.
Royal KD, Elahi F. Psychometric properties of the Death Anxiety Scale (DAS) among terminally ill cancer patients. J Psychosoc Oncol. 2011;29:359-371.
Braunstein JW. An investigation of irrational beliefs and death anxiety as a function of HIV status. J Ration Emot Cogn Behav Ther. 2004;22:21-38.
López-Castedo A, Calle I. Psychometric properties of the Death Anxiety Scale (DAS) among HIV/AIDS patients. Psicothema, 2008;20:958-963.
Siew H, Chee L, Das S et al. Anxiety and depression in patients with coronoary hearth disease: a stady in a tertiary hospital. Iran J Med Sci. 2011;36:201-206.
Go AS, Mozzaffarian D, Roger VL et al. Executive summary: hearth disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation. 2013;127:143-152.
Puddu PE, Schiariti M, Torromeo C. Gender and Cardiovascular Mortality in Northern and Southern European Populations. Curr Pharm Des. 2016;22:3893-3904.
Go AS, Iribarren C, Chandra M et al. Statin and beta-blocker therapy and the initial presentation of coronary heart disease. Ann Intern Med. 2006;144:229-238.
Lloyd-Jones DM, Larson MG, Beiser A et al. Lifetime risk of developing coronary heart disease. Lancet. 1999;353:89-92.
Medrano MJ, Boix R, Cerrato E et al. Incidence and Prevalence of Ischaemic Heart Disease and Cerebrovascular Disease in Spain: a Systematic Review of the Literature. Rev Esp Salud Publica. 2006;80:5-15.
Ministerio de Sanidad y Consumo. Mortalidad por cáncer, por enfermedad isquémica del corazón, por enfermedades cerebrovasculares y por diabetes mellitus en España. Madrid: Ministerio de Sanidad y Consumo, 2006.
Ministerio de Sanidad, Servicios Sociales e Igualdad. Patrones de mortalidad en España, 2014. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad, 2017.
Ergin A, Muntner P, Sherwin R et al. Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States. Am J Med. 2004;117:219-227.
Dégano IR, Elosua R, Marrugat J. Epidemiology of Acute Coronary Syndromes in Spain: Estimation of the Number of Cases and Trends From 2005 to 2049. Rev Esp Cardiol. 2013;66:472-481.
Ferreira-González I. The Epidemiology of Coronary Heart Disease. Rev Esp Cardiol. 2014;67:139-144.
Templer DI. The construction and validation of a Death Anxiety Scale. J Gen Psychol. 1970;82:165-177.
Tomás-Sábado J, Gómez-Benito J. Psychometric properties of the Spanish form of Templer’s Death Anxiety Scale. Psychol Rep. 2002;91:1116-1120.
Tomás-Sábado J, Gómez-Benito J. Death anxiety, death depression, and death obsession: Conceptual approach and assessment instruments. Psicol Conductual. 2004;12:79-100.
Aradilla-Herrero A, Tomás-Sábado J, Gómez Benito J. Death attitudes and emotional intelligence in nursing students. Omega (Westport). 2012;66:39-55.
Abdel-Khalek AM. Death anxiety among Lebanese samples. Psychol Rep. 1991;68:924-926.
Abdel-Khalek AM. The Kuwait University Anxiety Scale: Psychometric properties. Psychol Rep. 2000;87:478-492.
Abdel-Khalek AM. Death anxiety, death depression, and death obsession: a general factor of death distressis evident: a reply. Psychol Rep. 2004;94:1212-1214.
Lonetto R, Fleming S, Mercer GW. The structure of Death Anxiety: A factor analytic study. J Pers Assess. 1979;43:388-392.
Saggino A, Kline P. Item factor analisis of the Italian version of the Death Anxiety Scale. J Clin Psychol. 1996;52:329-333.
Devins GM. Death anxiety and voluntary passive eutanasia: Influences of proximity to death and experiences with death in important other persons. J Consult Clin Psychol. 1979;47:301-309.
Warren WG, Chopra PN. Some reliability and validity considerations on Australian data from the Death Anxiety Scale. Omega (Westport). 1979;9:293-298.
Lonetto R, Templer DI. Death Anxiety. Washington: Hemisphere Publishing, 1986.
Carrobles JA, Remor E, Rodríguez-Alzamora L. Relationship of coping and perceived social support to emotional distress in people living with HIV. Psicothema. 2003;15:420-426.
Sinoff G. Thanatophobia (Death Anxiety) in the Elderly: The Problem of the Child’s Inability to Assess Their Own Parent’s Death Anxiety State. Front Med. 2017;4:11.
Shahdadi H, Rahdar Z, Mansouri A et al. The effect of family-centered empowerment model on the level of death anxiety and depression in hemodialysis patients. Revista Publicando. 2018;5:470-482.
Kula T, Erden M. Existential Anxiety and Religion. Journal of Academic Research in Religious Sciences. 2017;17:21-41.
Kimter N, Kotfegul O. A Research on the Relationship Between Death Anxiety and Religiosity in Adults. Journal of Sakarya University Faculty of Theology. 2017;19:55-82.
Downloads
Published
How to Cite
License
Copyright (c) 2019 Antonio López-Castedo, Rubén González-Rodríguez, Raquel Vázquez Pérez
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
